Current Information

	Click here to listen to Deborah Covington, DrPH, Senior Director, Registries and Epidemiology at Kendle address the latest issues on registries in an interview with Taren Grom, Editor, PharmaVOICE
	Kendle manages more pregnancy registries than any other CRO, including the oldest and largest ongoing pregnancy exposure registry ever conducted. Click here to learn more

Active Registries

Kendle's experience developing, implementing, and managing pregnancy registries is unsurpassed. We currently manage more pregnancy registries than any other CRO.

Below are links to our active pregnancy registry web sites for use by both patients and physicians.

Amevive^® Pregnancy Exposure Registry

Antiretroviral Pregnancy Registry

Avonex^® Pregnancy Exposure Registry

Betaseron^® Pregnancy Registry

Exenatide Pregnancy Registry

Lamotrigine Pregnancy Registry

Ribavirin Pregnancy Registry

Sumatriptan/Naratriptan/Treximet Pregnancy Registry

UCB AED Pregnancy Registry

Request Additional Information and Report

Amevive^® Pregnancy Exposure Registry

Pregnant patients exposed to Amevive^® within the 8 weeks prior to conception and during the pregnancy and who are still currently pregnant may contact the registry at:

Phone: 800-811-0104

Fax: 800-800-1052

Email: registries@kendle.com

Antiretroviral Pregnancy Registry

http://www.apregistry.com

Avonex^® Pregnancy Exposure Registry

Pregnant patients exposed to Avonex^® around the time of conception and during the first trimester of pregnancy and who are still currently pregnant may contact the registry at:

Phone: 800-811-0104

Fax: 800-800-1052

Email: registries@kendle.com

Betaseron^® Pregnancy Registry

Pregnant patients or healthcare providers of pregnant patients exposed to Betaseron^® at the time of conception (i.e., any time from the first day of the last menstrual period) and/or during pregnancy may contact the registry at:

Phone: 800-478-7049

Fax: 800-800-1052

Email: registries@kendle.com

Exenatide Pregnancy Registry

http://www.exenatidepregnancyregistry.com

Pregnant patients or health care providers of pregnant patients exposed to exenatide (BYETTA® injection or other formulations of exenatide) and/or one or more other non-insulin antidiabetic medications at the time of conception (i.e., on or after the first day of the last menstrual period) may contact the registry at:

Phone: 800-633-9081

Email: registries@kendle.com

Lamotrigine Pregnancy Registry

http://pregnancyregistry.gsk.com/lamotrigine.html

Additional forms are provided below:

pdf 30k	Enrollment Form
pdf 9k	Patient Log
pdf 27k	Follow-up Form

Ribavirin Pregnancy Registry

http://www.ribavirinpregnancyregistry.com

Sumatriptan/Naratriptan/Treximet Pregnancy Registry

http://pregnancyregistry.gsk.com/sumatriptan.html

Additional forms are provided below:

pdf 22k	Enrollment Form
pdf 9k	Patient Log
pdf 27k	Follow-up Form

UCB AED Pregnancy Registry

Pregnant patients or health care providers of pregnant patients who have been exposed to Keppra® or other UCB antiepileptic drug (AED) prior to conception and during pregnancy may contact the UCB AED Pregnancy Registry (formerly, the Keppra Pregnancy Registry) via

phone: 1-888-537-7734 (1-888-KEP-PREG)

fax: 1-800-800-1052

Email: registries@kendle.com

Please reference www.keppra.com for prescribing information.